First Time Loading...
M

Mayinglong Pharmaceutical Group Co Ltd
SSE:600993

Watchlist Manager
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Watchlist
Price: 27.05 CNY -1.21%
Updated: Apr 25, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

3.2B
-2%
Revenue
Growth Rates:
1 Year
-12%
3 Years
+27%
5 Years
+48%
7 Years
+66%
10 Years
+102%
456.9m
+0.1%
Operating Income
Growth Rates:
1 Year
-14%
3 Years
+23%
5 Years
+48%
7 Years
+121%
10 Years
+156%
481.3m
-1%
Net Income
Growth Rates:
1 Year
-6%
3 Years
+21%
5 Years
+135%
7 Years
+97%
10 Years
+154%

Earnings Waterfall
Mayinglong Pharmaceutical Group Co Ltd

Revenue
3.2B CNY
Cost of Revenue
-1.7B CNY
Gross Profit
1.5B CNY
Operating Expenses
-995.9m CNY
Operating Income
456.9m CNY
Other Expenses
24.5m CNY
Net Income
481.3m CNY

Income Statement
Mayinglong Pharmaceutical Group Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023
Revenue
Revenue
1 584
N/A
1 602
+1%
1 605
+0%
1 623
+1%
1 607
-1%
1 621
+1%
1 642
+1%
1 657
+1%
1 739
+5%
1 784
+3%
1 833
+3%
1 894
+3%
1 924
+2%
2 103
+9%
2 013
-4%
1 937
-4%
1 884
-3%
1 751
-7%
1 861
+6%
2 041
+10%
2 152
+5%
2 198
+2%
2 311
+5%
2 401
+4%
2 528
+5%
2 705
+7%
2 431
-10%
2 411
-1%
2 518
+4%
2 792
+11%
3 317
+19%
3 479
+5%
3 587
+3%
3 385
-6%
3 473
+3%
3 644
+5%
3 640
0%
3 532
-3%
3 416
-3%
3 245
-5%
3 194
-2%
Gross Profit
Cost of Revenue
(924)
(918)
(934)
(942)
(921)
(944)
(979)
(1 000)
(1 062)
(1 081)
(1 138)
(1 193)
(1 219)
(1 344)
(1 240)
(1 135)
(1 068)
(874)
(974)
(1 118)
(1 205)
(1 207)
(1 309)
(1 364)
(1 449)
(1 598)
(1 446)
(1 404)
(1 457)
(1 663)
(2 053)
(2 189)
(2 264)
(2 019)
(2 117)
(2 231)
(2 223)
(2 038)
(1 917)
(1 782)
(1 741)
Gross Profit
660
N/A
684
+4%
671
-2%
680
+1%
686
+1%
677
-1%
663
-2%
657
-1%
677
+3%
703
+4%
695
-1%
701
+1%
706
+1%
759
+8%
773
+2%
802
+4%
816
+2%
876
+7%
888
+1%
923
+4%
947
+3%
991
+5%
1 002
+1%
1 037
+3%
1 080
+4%
1 108
+3%
985
-11%
1 008
+2%
1 061
+5%
1 128
+6%
1 264
+12%
1 290
+2%
1 323
+3%
1 366
+3%
1 356
-1%
1 413
+4%
1 417
+0%
1 494
+5%
1 498
+0%
1 463
-2%
1 453
-1%
Operating Income
Operating Expenses
(482)
(502)
(486)
(487)
(491)
(492)
(484)
(471)
(477)
(499)
(480)
(480)
(499)
(529)
(522)
(540)
(561)
(602)
(595)
(620)
(638)
(673)
(665)
(694)
(706)
(720)
(639)
(658)
(690)
(759)
(856)
(883)
(879)
(901)
(879)
(899)
(883)
(988)
(983)
(1 007)
(996)
Selling, General & Administrative
(476)
(462)
(482)
(484)
(488)
(451)
(480)
(471)
(476)
(452)
(480)
(478)
(499)
(485)
(528)
(538)
(556)
(566)
(591)
(617)
(631)
(632)
(648)
(664)
(680)
(669)
(595)
(611)
(636)
(715)
(818)
(838)
(834)
(819)
(827)
(842)
(821)
(891)
(911)
(944)
(936)
Research & Development
0
(26)
0
0
0
(26)
0
0
0
(29)
0
0
0
(31)
0
0
(9)
(38)
0
0
(19)
(39)
(30)
(44)
(45)
(53)
(53)
(51)
(54)
(53)
(60)
(70)
(68)
(62)
(70)
(72)
(79)
(72)
(77)
(71)
(67)
Depreciation & Amortization
0
(13)
0
0
0
(14)
0
0
0
(17)
0
0
0
(12)
0
0
0
(11)
0
0
0
(13)
0
0
0
(14)
0
0
0
(16)
0
0
0
(36)
0
0
0
(43)
0
0
0
Other Operating Expenses
(5)
(1)
(4)
(4)
(3)
(1)
(4)
(0)
(2)
(1)
(1)
(2)
(0)
(1)
6
(2)
4
12
(4)
(3)
13
12
13
14
19
17
8
4
(1)
24
22
24
22
16
17
15
17
18
6
8
7
Operating Income
179
N/A
183
+2%
186
+2%
193
+4%
195
+1%
185
-5%
180
-3%
186
+3%
200
+7%
204
+2%
215
+5%
221
+3%
206
-7%
230
+11%
251
+9%
262
+4%
255
-3%
274
+7%
292
+7%
303
+3%
309
+2%
318
+3%
337
+6%
342
+1%
374
+9%
388
+4%
345
-11%
350
+1%
371
+6%
369
0%
408
+11%
406
0%
444
+9%
465
+5%
477
+3%
514
+8%
534
+4%
507
-5%
516
+2%
456
-12%
457
+0%
Pre-Tax Income
Interest Income Expense
27
20
17
20
28
25
37
43
18
34
28
27
47
32
31
34
62
91
54
(21)
(83)
(121)
(65)
(13)
30
43
48
94
96
111
104
110
93
83
89
56
64
49
113
130
128
Non-Reccuring Items
0
0
0
0
0
5
0
0
0
(1)
0
0
0
8
0
9
9
1
(0)
0
0
(4)
0
0
0
(6)
0
4
4
21
8
7
7
3
0
(0)
5
(0)
(2)
0
(3)
Gain/Loss on Disposition of Assets
0
(0)
(0)
1
0
(1)
0
(1)
(1)
(0)
4
7
7
(1)
4
0
0
(0)
0
0
0
(0)
0
0
0
(1)
0
0
0
(1)
0
0
0
(0)
0
0
0
(0)
0
0
0
Total Other Income
13
12
13
10
9
8
7
10
13
11
11
9
10
10
3
(1)
(9)
(1)
(8)
(5)
(1)
(1)
(2)
(2)
(2)
(1)
(2)
(2)
(3)
(2)
(3)
(3)
(3)
(2)
(3)
(2)
(2)
4
4
2
1
Pre-Tax Income
218
N/A
215
-1%
216
+0%
224
+4%
232
+4%
222
-4%
223
+0%
238
+7%
229
-4%
248
+8%
257
+4%
265
+3%
271
+2%
280
+3%
289
+3%
304
+5%
318
+4%
365
+15%
339
-7%
276
-18%
225
-18%
192
-15%
271
+41%
327
+21%
403
+23%
422
+5%
391
-7%
445
+14%
467
+5%
498
+7%
517
+4%
521
+1%
541
+4%
548
+1%
563
+3%
568
+1%
601
+6%
559
-7%
630
+13%
589
-7%
583
-1%
Net Income
Tax Provision
(36)
(37)
(37)
(35)
(37)
(30)
(31)
(33)
(32)
(37)
(38)
(39)
(40)
(47)
(48)
(51)
(54)
(56)
(52)
(41)
(30)
(27)
(40)
(47)
(62)
(69)
(65)
(68)
(69)
(67)
(72)
(67)
(69)
(74)
(70)
(82)
(87)
(79)
(98)
(87)
(88)
Income from Continuing Operations
181
178
179
189
195
192
193
205
198
211
219
226
231
233
241
253
264
309
287
235
195
165
231
280
340
353
327
376
398
431
445
454
472
474
493
486
514
480
532
502
495
Income to Minority Interest
8
9
10
10
10
9
11
10
9
12
10
12
14
17
16
14
15
11
15
13
10
12
10
10
8
7
10
2
(2)
(12)
(18)
(15)
(15)
(9)
(8)
(4)
(1)
(1)
(3)
(13)
(14)
Net Income (Common)
189
N/A
186
-2%
188
+1%
199
+6%
205
+3%
202
-2%
203
+1%
215
+6%
207
-4%
223
+8%
230
+3%
238
+4%
245
+3%
250
+2%
257
+3%
266
+4%
279
+5%
320
+15%
302
-6%
248
-18%
205
-17%
176
-14%
241
+37%
291
+21%
349
+20%
360
+3%
337
-7%
378
+12%
396
+5%
419
+6%
427
+2%
439
+3%
457
+4%
465
+2%
485
+4%
482
-1%
513
+6%
479
-7%
529
+10%
488
-8%
481
-1%
EPS (Diluted)
0.44
N/A
0.43
-2%
0.44
+2%
0.47
+7%
0.48
+2%
0.47
-2%
0.47
N/A
0.49
+4%
0.48
-2%
0.52
+8%
0.54
+4%
0.56
+4%
0.57
+2%
0.58
+2%
0.59
+2%
0.61
+3%
0.64
+5%
0.74
+16%
0.7
-5%
0.58
-17%
0.48
-17%
0.41
-15%
0.56
+37%
0.68
+21%
0.82
+21%
0.84
+2%
0.78
-7%
0.87
+12%
0.91
+5%
0.97
+7%
0.99
+2%
1.02
+3%
1.06
+4%
1.08
+2%
1.12
+4%
1.12
N/A
1.19
+6%
1.11
-7%
1.23
+11%
1.13
-8%
1.12
-1%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 131,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.